Dyadic International (Dyadic International) EV-to-Revenue

: 12.43 (As of Today)

View and export this data going back to 2004. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Dyadic International's enterprise value is $36.05 Mil. Dyadic International's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2.90 Mil. Therefore, Dyadic International's EV-to-Revenue for today is 12.43.

The historical rank and industry rank for Dyadic International's EV-to-Revenue or its related term are showing as below:

DYAI' s EV-to-Revenue Range Over the Past 10 Years
Min: -53.36 Med: 13.1 Max: 198.25
Current: 12.43

During the past 13 years, the highest EV-to-Revenue of Dyadic International was 198.25. The lowest was -53.36. And the median was 13.10.

DYAI's EV-to-Revenue is ranked worse than
61.72% of 1032 companies
in the Biotechnology industry
Industry Median: 7.64 vs DYAI: 12.43

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-24), Dyadic International's stock price is $1.5207. Dyadic International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.10. Therefore, Dyadic International's PS Ratio for today is 15.06.

Dyadic International EV-to-Revenue Historical Data

The historical data trend for Dyadic International's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dyadic International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

63.95

74.17

44.65

7.68

13.54

Dyadic International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															7.68	12.13	13.22	16.00	13.54

Competitive Comparison

For the Biotechnology subindustry, Dyadic International's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dyadic International EV-to-Revenue Distribution

For the Biotechnology industry and Healthcare sector, Dyadic International's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Dyadic International's EV-to-Revenue falls into.

Dyadic International EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Dyadic International's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	36.045	/	2.899
	=	12.43

Dyadic International's current Enterprise Value is $36.05 Mil.
Dyadic International's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.90 Mil.

Dyadic International (NAS:DYAI) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Dyadic International's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	1.5207	/	0.101
	=	15.06

Dyadic International's share price for today is $1.5207.
Dyadic International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.10.

Dyadic International EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dyadic International's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Dyadic International (Dyadic International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dyadic International Inc (NAS:DYAI) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

140 Intracoastal Pointe Drive, Suite 404, Jupiter, FL, USA, 33477

Website

https://www.dyadic.com

Dyadic International Inc is a global biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Executives

Ronen Tchelet	officer: VP of Research and Bus. Dvlpmt	140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Mark A Emalfarb	director, 10 percent owner, officer: President, CEO & Chairman	C/O DYADIC INTERNATIONAL, INC., 140 INTRACOASTAL POINT DRIVE, SUITE 404, JUPITER FL 33477-5094
Joseph P Hazelton	officer: Chief Business Officer	140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER FL 33477
Francisco Trust Under Agreement Dated February 28, 1996	10 percent owner	C/O ROBERT S. LEVIN, ESQ., TRUSTEE, 180 NORTH LASALLE STREET, SUITE 3200, CHICAGO IL 60601
Patrick K. Lucy	director	C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Matthew S. Jones	officer: Managing Dir of BD & Licensing	140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Seth Herbst	director	140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Barry Buckland	director	C/O DYADIC INTERNATIONAL, INC., 140 INTERCOASTAL POINTE DR SUITE 404, JUPITER FL 33477
Ping Wang Rawson	officer: Chief Financial Officer	140 INTRACOASTAL POINTE DRIVE, SUITE 404, JUPITER X1 33477
Michael P. Tarnok	director	KERYX BIOPHARMACEUTICALS, INC., 750 LEXINGTON AVENUE, NEW YORK NY 10022
Arindam Bose	director	4452 BELTWAY DRIVE, ADDISON TX 75001
Jack Kaye	director	C/O KERYX BIOPHARMACEUTICALS, 750 LEXINGTON AVENUE, NEW YORK X1 10022
Tom Juda	10 percent owner	410 S LUCERNE BLVD, LOS ANGELES CA 90020
John Steven Emerson	10 percent owner	1522 ENSLEY AVENUE, LOS ANGELES CA 90024
Nancy Juda	10 percent owner	410 S LUCERNE BLVD, LOS ANGELES CA 90020